Evidence-Based and Tailored Medication in Type 2 Diabetes: A Pathway Learned From Clinical Trials

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0834-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Importance of Evidence Based Therapy for Diabetes Type 2

Saudi Journal of Internal Medicine
2012English

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

A Review of Clinical Trials in Emerging Botanical Interventions for Type 2 Diabetes Mellitus

2011English

Evidence-Based Medicine of Screening of Diabetic Retinopathy Among Type 2 Diabetes: A Clinical Overview

Health
2015English

Medication Adherence and Clinical Outcomes in Type 2 Diabetes Mellitus Patients With Depression: A Prospective Interventional Study

Journal of Research in Pharmacy
2018English

Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children: A Prospective National Surveillance Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Antipsychotic Medication and Type 2 Diabetes and Impaired Glucose Regulation

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2018English

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2017English

Treatment Choice, Medication Adherence and Glycemic Efficacy in People With Type 2 Diabetes: A UK Clinical Practice Database Study

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy